Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its lead molecule inebilizumab, is a humanized monoclonal antibody, or mAb, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.

Related Companies

TickerCompanyChg %Mkt Cap

undefined Frequently Asked Questions

Q

How do I buy undefined (VIE) stock?

A

You can purchase shares of (: ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are undefined's (VIE) competitors?

A

There are no as such competitors for .

Q

What is the target price for undefined (VIE) stock?

A

There is no analysis for

Q

Current Stock Price for undefined (VIE)?

A

The stock price for (: ) is $ last updated Invalid Date.

Q

Does undefined (VIE) pay a dividend?

A

There are no upcoming dividends for .

Q

When is undefined (undefined:VIE) reporting earnings?

A

does not have any upcoming earnings scheduled.

Q

Is undefined (VIE) going to split?

A

There is no upcoming split for .

Q

What sector and industry does undefined (VIE) operate in?

A

is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .